Tag: revance therapeutics

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management
FDA Accepts Revance Resubmission for Frown Line Treatment
FDA Approves Revance Daxxify for Frown Lines
Studies Show Efficacy of Daxxify to Treat Frown Lines
Revance Publishes 2 Papers on Daxxify Injectable
Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio

All

Sorry, No Posts Found

All

Aesthetic Record Acquires JOYA Health to Link Providers with Employee Benefit Programs

The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.

Dermalogica Debuts PRO Pen, Its First Medical Aesthetic Device
New Guidebook Focuses on Recovery After Aesthetic Procedures
Laser Treatment Improves Actinic Keratosis, but ‘Molecular Scar’ May Persist, Study Finds

Tag: revance therapeutics

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management

FDA Accepts Revance Resubmission for Frown Line Treatment

FDA Approves Revance Daxxify for Frown Lines

Studies Show Efficacy of Daxxify to Treat Frown Lines

Revance Publishes 2 Papers on Daxxify Injectable

Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio

All

Sorry, No Posts Found

All

Aesthetic Record Acquires JOYA Health to Link Providers with Employee Benefit Programs

Dermalogica Debuts PRO Pen, Its First Medical Aesthetic Device

New Guidebook Focuses on Recovery After Aesthetic Procedures

Laser Treatment Improves Actinic Keratosis, but ‘Molecular Scar’ May Persist, Study Finds

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links